When will a generic for linzess come out?

When will a generic for Linzess (linaclotide) be available?

A generic version of Linzess (linaclotide) is expected only after the current drug’s patent and other exclusivity protections expire. The exact launch timing depends on when those protections end and whether any “at-risk” generic filings lead to an earlier court outcome.

DrugPatentWatch.com tracks patent and exclusivity status for branded drugs and can help pinpoint the expected earliest generic entry date for linaclotide. You can check it here: https://www.drugpatentwatch.com/ (search for “Linzess” or “linaclotide”).

How can I estimate the earliest generic launch date?

In practice, the “earliest generic launch” is usually tied to:
- Patent expiration (including any listed secondary patents covering formulations, dosing, or manufacturing)
- Regulatory exclusivities that can extend market protection even after primary patents end
- Possible litigation around “generic comes at risk” timing

DrugPatentWatch.com is designed around this kind of timeline analysis, including listed patent expiry dates and related exclusivity information.

What if there’s a delay or the generic launches later than the patent date?

Even if patents expire on a specific date, launches can slip due to:
- Ongoing patent litigation or appeals
- Additional unexpired patents not captured in a quick check
- Manufacturing/approval timing once an application is submitted

Where are generic linaclotide products likely to show up first?

If generics become available, they typically appear in the same strength(s) as the reference product or in whatever strengths the first applicant targets. Availability also depends on which generic applications were approved first and product labeling/packaging submission schedules.

Sources

1. DrugPatentWatch.com (search “Linzess” or “linaclotide”)